Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.
about
Transformative tools for tackling tuberculosisInadequate clearance of translocated bacterial products in HIV-infected humanized miceTuberculosis vaccines: barriers and prospects on the quest for a transformative toolA plasma biomarker signature of immune activation in HIV patients on antiretroviral therapyCoordinated regulation of SIV replication and immune responses in the CNS.Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques.Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine developmentRelationship between inflammatory mediator patterns and anemia in HIV-1 positive and exposed children with Plasmodium falciparum malariaActivation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infectionThe role of cytokines in the establishment, persistence and eradication of the HIV reservoirShort-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection
P2860
Q26784084-2502ACB2-A1E4-4CB8-9F5B-4A5D404892E4Q27314977-D80F72E5-2B19-4868-A153-891A2BB1CD81Q28390218-169FF8C8-EDD9-40F7-AE59-9C7A849A7469Q28480936-95B74D50-2B22-4997-85A2-B6768760311AQ33519523-D6A81008-C063-4308-B073-8C5116E2F0F7Q34412070-6717395C-84BC-4F43-9D43-FAA6C14BB39AQ34671609-B84D8DB0-B8BC-4E86-B93C-D7CBCF68FD05Q35158952-D3E6CB5F-75EA-48D8-A665-6D2EF2AFA147Q36162133-003B1A09-A7DD-4561-8D34-70CE0FE5663EQ36436664-3D869035-62AE-4F95-96AF-70462FCD6433Q36619693-36D92F6A-8BA3-45B9-A133-9591BCFCCD4FQ37157209-C1D5D06F-0411-408B-B21E-5B6FD11D897DQ41899294-A165C51A-766E-4A16-B5DB-8CDCEF7983C9Q57583339-F8CCFB51-9C14-4CA2-9409-DB7D616FD8D9
P2860
Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@en
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@nl
type
label
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@en
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@nl
prefLabel
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@en
Immune activation and IL-12 pr ...... ctive, antiretroviral therapy.
@nl
P2093
P2860
P356
P1476
Immune activation and IL-12 pr ...... active, antiretroviral therapy
@en
P2093
Adriana A Byrnes
Beulah P Sabundayo
David M Harris
Sowsan F Atabani
Susan J Langan
P2860
P304
P356
10.1189/JLB.0708438
P577
2008-09-19T00:00:00Z